{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:26:07Z","timestamp":1773102367474,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2021-13793\/SCR-BMS"],"award-info":[{"award-number":["2021-13793\/SCR-BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Aravind Medical Research Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10475-6","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:28:41Z","timestamp":1744194521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigation of GD2 synthase as a potential marker for retinoblastoma poor prognosis"],"prefix":"10.1007","volume":"52","author":[{"given":"Rathinavel","family":"Sethu Nagarajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhakrishnan","family":"Shanthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayyasamy","family":"Vanniarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"10475_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41433-018-0244-7","volume":"33","author":"M Jain","year":"2019","unstructured":"Jain M, Rojanaporn D, Chawla B et al (2019) Retinoblastoma in Asia. Eye 33:87\u201396. https:\/\/doi.org\/10.1038\/s41433-018-0244-7","journal-title":"Eye"},{"key":"10475_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4103\/ojo.ojo_176_22","volume":"16","author":"CL Kakarala","year":"2023","unstructured":"Kakarala CL, Raval VR, Mallu A et al (2023) Metastatic retinoblastoma at presentation: clinical presentation, treatment, and outcomes. Oman J Ophthalmol 16:524\u2013528. https:\/\/doi.org\/10.4103\/ojo.ojo_176_22","journal-title":"Oman J Ophthalmol"},{"key":"10475_CR3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/s12887-023-04347-w","volume":"23","author":"MO Atima","year":"2023","unstructured":"Atima MO, Idakwo U, Komolafe O et al (2023) Presentation pattern and survival rate of retinoblastoma following chemotherapy: a prospective study. BMC Pediatr 23:538. https:\/\/doi.org\/10.1186\/s12887-023-04347-w","journal-title":"BMC Pediatr"},{"key":"10475_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/IAE.0000000000001962","volume":"39","author":"S Kaliki","year":"2019","unstructured":"Kaliki S, Patel A, Iram S et al (2019) RETINOBLASTOMA IN INDIA: clinical presentation and outcome in 1,457 patients (2,074 Eyes). Retina 39:379\u2013391. https:\/\/doi.org\/10.1097\/IAE.0000000000001962","journal-title":"Retina"},{"key":"10475_CR5","doi-asserted-by":"publisher","first-page":"904","DOI":"10.21037\/tp.2016.02.01","volume":"5","author":"A Purkayastha","year":"2016","unstructured":"Purkayastha A, Sharma N, Pathak A et al (2016) An extremely rare case of metastatic retinoblastoma of Parotids presenting as a massive swelling in a child. Transl Pediatr 5:904\u2013994. https:\/\/doi.org\/10.21037\/tp.2016.02.01","journal-title":"Transl Pediatr"},{"key":"10475_CR6","doi-asserted-by":"publisher","first-page":"e380","DOI":"10.1016\/S2214-109X(21)00555-6","volume":"10","author":"ES Wong","year":"2022","unstructured":"Wong ES, Choy RW, Zhang Y et al (2022) Global retinoblastoma survival and Globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors. Lancet Glob Health 10:e380\u2013e389. https:\/\/doi.org\/10.1016\/S2214-109X(21)00555-6","journal-title":"Lancet Glob Health"},{"key":"10475_CR7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4103\/0301-4738.97077","volume":"61","author":"MJ Ali","year":"2013","unstructured":"Ali MJ, Honavar SG, Reddy VA (2013) Distant metastatic retinoblastoma without central nervous system involvement. Indian J Ophthalmol 61:357\u2013359. https:\/\/doi.org\/10.4103\/0301-4738.97077","journal-title":"Indian J Ophthalmol"},{"key":"10475_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12886-018-0772-8","volume":"18","author":"H Hu","year":"2018","unstructured":"Hu H, Zhang W, Wang Y et al (2018) Characterization, treatment and prognosis of retinoblastoma with central nervous system metastasis. BMC Ophthalmol 18:107. https:\/\/doi.org\/10.1186\/s12886-018-0772-8","journal-title":"BMC Ophthalmol"},{"key":"10475_CR9","doi-asserted-by":"publisher","first-page":"100058","DOI":"10.1016\/j.apjo.2024.100058","volume":"13","author":"M Zhou","year":"2024","unstructured":"Zhou M, Tang J, Fan J et al (2024) Recent progress in retinoblastoma: pathogenesis, presentation, diagnosis and management. Asia-Pac J Ophthalmol 13:100058. https:\/\/doi.org\/10.1016\/j.apjo.2024.100058","journal-title":"Asia-Pac J Ophthalmol"},{"key":"10475_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12886-020-01654-z","volume":"20","author":"MM Abusayf","year":"2020","unstructured":"Abusayf MM, Alkatan HM, Elkhamary S et al (2020) Histopathological assessment of optic nerve invasion guided by radiological findings in enucleated globes with retinoblastoma. BMC Ophthalmol 20:386. https:\/\/doi.org\/10.1186\/s12886-020-01654-z","journal-title":"BMC Ophthalmol"},{"key":"10475_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2045-8118-8-14","volume":"8","author":"CL Weston","year":"2011","unstructured":"Weston CL, Glantz MJ, Connor JR (2011) Detection of cancer cells in the cerebrospinal fluid: current methods and future directions. Fluids Barriers CNS 8:14. https:\/\/doi.org\/10.1186\/2045-8118-8-14","journal-title":"Fluids Barriers CNS"},{"key":"10475_CR12","first-page":"444","volume":"20","author":"HH Shehata","year":"2016","unstructured":"Shehata HH, Abou Ghalia AH, Elsayed EK et al (2016) Clinical significance of high levels of survivin and transforming growth factor beta-1 proteins in aqueous humor and serum of retinoblastoma patients. J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus 20:444. e1-444.e9","journal-title":"J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"10475_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.clinbiochem.2009.10.056","volume":"43","author":"HH Shehata","year":"2010","unstructured":"Shehata HH, Abou Ghalia AH, Elsayed EK et al (2010) Detection of survivin protein in aqueous humor and serum of retinoblastoma patients and its clinical significance. Clin Biochem 43:362\u2013366. https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.10.056","journal-title":"Clin Biochem"},{"key":"10475_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/tvst.8.2.13","volume":"8","author":"BK Ghiam","year":"2019","unstructured":"Ghiam BK, Xu L, Berry JL (2019) Aqueous humor markers in retinoblastoma, a review. Transl Vis Sci Technol 8:13. https:\/\/doi.org\/10.1167\/tvst.8.2.13","journal-title":"Transl Vis Sci Technol"},{"key":"10475_CR15","doi-asserted-by":"publisher","unstructured":"Gu Y, Suarez-Pizarro M, Chen CC et al (2025) UHRF1 is critical for tumor-promoting inflammation and tumorigenesis in retinoblastoma. bioRxiv 2025.03.02.641083. https:\/\/doi.org\/10.1101\/2025.03.02.641083","DOI":"10.1101\/2025.03.02.641083"},{"key":"10475_CR16","doi-asserted-by":"publisher","first-page":"e30717","DOI":"10.1002\/pbc.30717","volume":"71","author":"R Aschero","year":"2024","unstructured":"Aschero R, Ganiewich D, Lamas G et al (2024) Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma. Pediatr Blood Cancer 71:e30717. https:\/\/doi.org\/10.1002\/pbc.30717","journal-title":"Pediatr Blood Cancer"},{"key":"10475_CR17","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1515\/CCLM.2006.260","volume":"44","author":"G Mitropapas","year":"2006","unstructured":"Mitropapas G, Nezos A, Halapas A et al (2006) Molecular detection of tyrosinase transcripts in peripheral blood from patients with malignant melanoma: correlation of PCR sensitivity threshold with clinical and pathologic disease characteristics. Clin Chem Lab Med CCLM 44:1403\u20131409. https:\/\/doi.org\/10.1515\/CCLM.2006.260","journal-title":"Clin Chem Lab Med CCLM"},{"key":"10475_CR18","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/ijc.2910530614","volume":"53","author":"J Portoukalian","year":"1993","unstructured":"Portoukalian J, David M, Richard M, Gain P (1993) Shedding of GD2 ganglioside in patients with retinoblastoma. Int J Cancer 53:948\u2013951. https:\/\/doi.org\/10.1002\/ijc.2910530614","journal-title":"Int J Cancer"},{"key":"10475_CR19","doi-asserted-by":"publisher","first-page":"13523","DOI":"10.1038\/s41598-024-60052-3","volume":"14","author":"AM Bhat","year":"2024","unstructured":"Bhat AM, Mohapatra BC, Luan H et al (2024) GD2 and its biosynthetic enzyme GD3 synthase promote tumorigenesis in prostate cancer by regulating cancer stem cell behavior. Sci Rep 14:13523. https:\/\/doi.org\/10.1038\/s41598-024-60052-3","journal-title":"Sci Rep"},{"key":"10475_CR20","doi-asserted-by":"publisher","first-page":"1371345","DOI":"10.3389\/fimmu.2024.1371345","volume":"15","author":"J Philippova","year":"2024","unstructured":"Philippova J, Shevchenko J, Sennikov S (2024) GD2-targeting therapy: a comparative analysis of approaches and promising directions. Front Immunol 15:1371345. https:\/\/doi.org\/10.3389\/fimmu.2024.1371345","journal-title":"Front Immunol"},{"key":"10475_CR21","doi-asserted-by":"publisher","unstructured":"Nazha B, Inal C, Owonikoko TK (2020) Disialoganglioside GD2 expression in solid tumors and role as a target for cancer therapy. Front Oncol 10. https:\/\/doi.org\/10.3389\/fonc.2020.01000","DOI":"10.3389\/fonc.2020.01000"},{"key":"10475_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12032-024-02391-9","volume":"41","author":"S Balaji","year":"2024","unstructured":"Balaji S, Rao A, Saraswathi KK et al (2024) Focused cancer pathway analysis revealed unique therapeutic targets in retinoblastoma. Med Oncol Northwood Lond Engl 41:168. https:\/\/doi.org\/10.1007\/s12032-024-02391-9","journal-title":"Med Oncol Northwood Lond Engl"},{"key":"10475_CR23","unstructured":"Researcher Formula for Copy Number Calculation| IDT https:\/\/www.idtdna.com\/pages\/education\/decoded\/article\/calculations-converting-from-nanograms-to-copy-number. Accessed 18 Dec 2024"},{"key":"10475_CR24","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.3390\/ijms22052622","volume":"22","author":"\u00c1 Bartha","year":"2021","unstructured":"Bartha \u00c1, Gy\u0151rffy B (2021) TNMplot.com: A web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci 22:2622. https:\/\/doi.org\/10.3390\/ijms22052622","journal-title":"Int J Mol Sci"},{"key":"10475_CR25","doi-asserted-by":"publisher","unstructured":"Machy P, Mortier E, Birkl\u00e9 S (2023) Biology of GD2 ganglioside: implications for cancer immunotherapy. Front Pharmacol 14. https:\/\/doi.org\/10.3389\/fphar.2023.1249929","DOI":"10.3389\/fphar.2023.1249929"},{"key":"10475_CR26","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.2147\/OTT.S228532","volume":"13","author":"H Wang","year":"2020","unstructured":"Wang H, Yang J, Pan H et al (2020) Dinutuximab synergistically enhances the cytotoxicity of natural killer cells to retinoblastoma through the Perforin-Granzyme B pathway. OncoTargets Ther Volume 13:3903\u20133920. https:\/\/doi.org\/10.2147\/OTT.S228532","journal-title":"OncoTargets Ther Volume"},{"key":"10475_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.47176\/mjiri.35.148","volume":"35","author":"M Mansoori","year":"2021","unstructured":"Mansoori M, Mirzaei A, Abdi Rad I et al (2021) Upregulation of ganglioside GD2 synthase (GD2S), as a new putative cancer stem cell marker in breast carcinomas. Med J Islam Repub Iran 35:148. https:\/\/doi.org\/10.47176\/mjiri.35.148","journal-title":"Med J Islam Repub Iran"},{"key":"10475_CR28","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/1097-0142(20010815)92:4<924::aid-cncr1402>3.0.co;2-o","volume":"92","author":"MS Lo Piccolo","year":"2001","unstructured":"Lo Piccolo MS, Cheung NK, Cheung IY (2001) GD2 synthase: a new molecular marker for detecting neuroblastoma. Cancer 92:924\u2013931. https:\/\/doi.org\/10.1002\/1097-0142(20010815)92:4<924::aid-cncr14023.0.co;2-o","journal-title":"Cancer"},{"key":"10475_CR29","doi-asserted-by":"publisher","unstructured":"Alonso (2010) Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma. Mol Med Rep 3. https:\/\/doi.org\/10.3892\/mmr_000000248","DOI":"10.3892\/mmr_000000248"},{"key":"10475_CR30","doi-asserted-by":"publisher","first-page":"721","DOI":"10.20517\/cdr.2022.30","volume":"5","author":"K Nguyen","year":"2022","unstructured":"Nguyen K, McConnell E, Edwards O et al (2022) GD2\u2009+\u2009cancer stem cells in triple-negative breast cancer: mechanisms of resistance to breast cancer therapies. Cancer Drug Resist 5:721\u2013726. https:\/\/doi.org\/10.20517\/cdr.2022.30","journal-title":"Cancer Drug Resist"},{"key":"10475_CR31","doi-asserted-by":"publisher","first-page":"29828","DOI":"10.1074\/jbc.M414041200","volume":"280","author":"W Aixinjueluo","year":"2005","unstructured":"Aixinjueluo W, Furukawa K, Zhang Q et al (2005) Mechanisms for the apoptosis of small cell lung cancer cells induced by Anti-GD2 monoclonal antibodies. J Biol Chem 280:29828\u201329836. https:\/\/doi.org\/10.1074\/jbc.M414041200","journal-title":"J Biol Chem"},{"key":"10475_CR32","doi-asserted-by":"publisher","unstructured":"Yesmin F, Bhuiyan RH, Ohmi Y et al (2022) Ganglioside GD2 enhances the malignant phenotypes of melanoma cells by cooperating with integrins. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms23010423","DOI":"10.3390\/ijms23010423"},{"key":"10475_CR33","doi-asserted-by":"publisher","first-page":"e001197","DOI":"10.1136\/jitc-2020-001197","volume":"9","author":"S Ly","year":"2021","unstructured":"Ly S, Anand V, El-Dana F et al (2021) Anti-GD2 antibody Dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells. J Immunother Cancer 9:e001197. https:\/\/doi.org\/10.1136\/jitc-2020-001197","journal-title":"J Immunother Cancer"},{"key":"10475_CR34","doi-asserted-by":"publisher","first-page":"100971","DOI":"10.1016\/j.tranon.2020.100971","volume":"14","author":"J Sujjitjoon","year":"2021","unstructured":"Sujjitjoon J, Sayour E, Tsao S-T et al (2021) GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma\u2013 assessing tumor and T cell interaction. Transl Oncol 14:100971. https:\/\/doi.org\/10.1016\/j.tranon.2020.100971","journal-title":"Transl Oncol"},{"key":"10475_CR35","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/s43018-020-00119-y","volume":"1","author":"K Wang","year":"2020","unstructured":"Wang K, Chen Y, Ahn S et al (2020) GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision. Nat Cancer 1:990\u2013997. https:\/\/doi.org\/10.1038\/s43018-020-00119-y","journal-title":"Nat Cancer"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10475-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10475-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10475-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:24:21Z","timestamp":1766852661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10475-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10475"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10475-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was approved by Institutional Ethics Committee (IRB2017009BAS) and followed the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All samples were collected with the informed consent from patients\u2019 parents or legally authorized representatives.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"372"}}